verapamil has been researched along with Cholera Infantum in 9 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Verapamil and diltiazem have been shown in animals (opossum, baboon) to produce decreased contractions in esophageal smooth muscle, resulting in a decreased amplitude of peristalsis and decreased lower esophageal sphincter pressures." | 3.75 | Calcium-channel blocking agents for gastrointestinal disorders. ( Castell, DO, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| AlGusbi, S | 1 |
| Krücken, J | 1 |
| Ramünke, S | 1 |
| von Samson-Himmelstjerna, G | 1 |
| Demeler, J | 1 |
| Khan, M | 1 |
| Khan, AU | 2 |
| Gilani, AH | 2 |
| Prisant, LM | 1 |
| Spaulding, VC | 1 |
| Bashir, S | 1 |
| Fossati, C | 1 |
| Guistiniani, S | 1 |
| Belpomme, D | 1 |
| Gauthier, S | 1 |
| Pujade-Lauraine, E | 1 |
| Facchini, T | 1 |
| Goudier, MJ | 1 |
| Krakowski, I | 1 |
| Netter-Pinon, G | 1 |
| Frenay, M | 1 |
| Gousset, C | 1 |
| Marié, FN | 1 |
| Benmiloud, M | 1 |
| Sturtz, F | 1 |
| Larach, DR | 1 |
| Zelis, R | 1 |
| Castell, DO | 1 |
| Bleifeld, W | 1 |
| Merx, W | 1 |
| Effert, S | 1 |
3 reviews available for verapamil and Cholera Infantum
| Article | Year |
|---|---|
[Side-effects of calcium antagonists].
Topics: Calcium Channel Blockers; Cardiovascular Diseases; Drug Hypersensitivity; Drug Interactions; Fendili | 1984 |
Advances in calcium blocker therapy.
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Asthma; Blood Platelet Disorders; Calcium; Calcium Channel B | 1986 |
Calcium-channel blocking agents for gastrointestinal disorders.
Topics: Animals; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Esophageal Achalasia; Esopha | 1985 |
2 trials available for verapamil and Cholera Infantum
| Article | Year |
|---|---|
Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma.
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protoc | 2000 |
Calcium-channel blocking agents for gastrointestinal disorders.
Topics: Animals; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Esophageal Achalasia; Esopha | 1985 |
5 other studies available for verapamil and Cholera Infantum
| Article | Year |
|---|---|
Analysis of putative inhibitors of anthelmintic resistance mechanisms in cattle gastrointestinal nematodes.
Topics: Albendazole; Animals; Anthelmintics; Biological Assay; Calcium Channel Blockers; Cattle; Drug Resist | 2014 |
Pharmacological explanation for the medicinal use of Juniperus excelsa in hyperactive gastrointestinal and respiratory disorders.
Topics: Animals; Bronchodilator Agents; Calcium Channel Blockers; Diarrhea; Gastrointestinal Diseases; Guine | 2012 |
Antihypertensive pharmacobezoar.
Topics: Antihypertensive Agents; Bezoars; Calcium Channel Blockers; Drug Delivery Systems; Gastrointestinal | 2006 |
Pharmacological basis for the use of Borago officinalis in gastrointestinal, respiratory and cardiovascular disorders.
Topics: Animals; Aorta; Borago; Calcium; Cardiovascular Diseases; Dose-Response Relationship, Drug; Female; | 2007 |
[Clinical pharmacology and adverse effects of various anti-arrhythmic drugs].
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Bone Marrow Diseases; Central Nervous Sys | 1971 |